Human Genome Epidemiology Literature Finder
|
Records 1 - 3 (of 3 Records) |
| Query Trace: Lung Neoplasms and CYP4B1[original query] |
|---|
| Association between cancer risk and drug-metabolizing enzyme gene (CYP2A6, CYP2A13, CYP4B1, SULT1A1, GSTM1, and GSTT1) polymorphisms in cases of lung cancer in Japan. Drug metabolism and pharmacokinetics 2011 26 (5): 516-22. Tamaki Yuichiro, Arai Tomio, Sugimura Haruhiko, Sasaki Takamitsu, Honda Masashi, Muroi Yuka, Matsubara Yoichi, Kanno Shuichi, Ishikawa Masaaki, Hirasawa Noriyasu, Hiratsuka Masahi |
| Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis. Cancer chemotherapy and pharmacology 2015 Nov . Arbitrio Mariamena, Di Martino Maria Teresa, Barbieri Vito, Agapito Giuseppe, Guzzi Pietro Hiram, Botta Cirino, Iuliano Eleonora, Scionti Francesca, Altomare Emanuela, Codispoti Stefania, Conforti Serafino, Cannataro Mario, Tassone Pierfrancesco, Tagliaferri Pierosand |
| Missense variants in CYP4B1 associated with increased risk of lung cancer among Chinese Han population. World journal of surgical oncology 2023 11 21 (1): 352. Yongqin Yang, Shan Yuan, Shouchun Yan, Kuaini Dong, Yonghui Ya |
- Page last reviewed:Feb 1, 2024
- Content source:

